ST. LOUIS, Aug. 21 /PRNewswire-FirstCall/ -- Sigma-Aldrich(R) announced today that scientists at its new Sigma Advanced Genetic Engineering (SAGE(TM)) Labs in St. Louis will leverage its exclusive CompoZr(TM) Zinc Finger Nuclease (ZFN) gene editing technology (www.compozrzfn.com) to define, develop and offer a new generation of genetically-engineered rodent research models. Such models are commonly used to study disease states in humans and play a key role in the drug discovery process.
"The Knockout Rat is a long-awaited milestone in the scientific community, and we are pleased that Sigma innovation has played such a key role in its development. Applying our proprietary CompoZr ZFN technology in this very practical application has provided researchers with a powerful new tool to study human diseases. The potential applications using these rodent models of human disease could ultimately eliminate years of research time and save millions of lives," said Dr. Dave Smoller, President, Sigma Research Biotechnology.
Sigma-Aldrich is the premiere resource for commercial zinc finger nucleases and markets its CompoZr ZFN products and services based on an exclusive partnership with Sangamo BioSciences. For more information on SAGE Labs or our gene-editing technologies, visit www.sigma.com/sagelabs.
Cautionary Statement: This release contains forward-looking statements relating to future performance, goals, strategic actions and initiatives and similar intentions and beliefs and other statements regarding the Company's expectations, goals, beliefs, intentions and the like, which involve assumptions regarding the Company's operations and conditions in the markets the Company serves. The Company does not undertake any obligation to update these forward-looking statements.
Photo: http://www.newscom.com/cgi-bin/prnh/20050215/CGSIGMAALLOGO
http://photoarchive.ap.org
PRN Photo Desk, photodesk@prnewswire.comSigma-Aldrich
